BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2950629)

  • 1. Effects of cyclosporine metabolites M17 and M18 on proliferation and interleukin 2 production in the mixed lymphocyte culture.
    Freed BM; Rosano TG; Quick C; Lempert N
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1223-6. PubMed ID: 2950629
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of the in vitro immunosuppressive effects of cyclosporine A and its metabolites.
    Copeland KR; Yatscoff RW; Rush D; Jeffery JR
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1449-52. PubMed ID: 2523585
    [No Abstract]   [Full Text] [Related]  

  • 3. Cyclosporin A and prednisolone: an additive inhibitory effect of cell proliferation and interleukin-2 production.
    Manfro RC; Pohanka E; Tomlanovich S; Benet LZ; Garovoy MR
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1457-9. PubMed ID: 2523586
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of FK 506 and low concentration cyclosporine on human lymphocyte activation antigen expression: a flow cytometric analysis.
    Woo J; Sewell HF; Thomson AW
    Transplant Proc; 1990 Aug; 22(4):1645-6. PubMed ID: 1697113
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunosuppressive activities of cyclosporine metabolites M17 and M21 within a bioassay based on inhibition of interleukin-2 production.
    Heidecke CD; Nicolaus C; Schäfer K; Groenewoud B; Bollschweiler E; Hölscher M
    Transplant Proc; 1989 Feb; 21(1 Pt 1):839. PubMed ID: 2784905
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on the biologic activities of Sandimmun metabolites in humans and in animal models: review and original experiments.
    Fahr A; Hiestand P; Ryffel B
    Transplant Proc; 1990 Jun; 22(3):1116-24. PubMed ID: 2140916
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacodynamics of cyclosporine.
    Kahan BD; Yoshimura N; Pellis NR; Burstain T; Van Buren CT; Leinikki P; Schreiber RD; Roesel TR; Kerman RH
    Transplant Proc; 1986 Dec; 18(6 Suppl 5):238-51. PubMed ID: 2947366
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunosuppressive activity of cyclosporine metabolites in vitro.
    Schlitt HJ; Christians U; Wonigeit K; Sewing KF; Pichlmayr R
    Transplant Proc; 1987 Oct; 19(5):4248-51. PubMed ID: 2960052
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro immunosuppressive properties of cyclosporine metabolites.
    Freed BM; Rosano TG; Lempert N
    Transplantation; 1987 Jan; 43(1):123-7. PubMed ID: 2948307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catalase increases lymphocyte proliferation in mixed lymphocyte culture.
    Rush DN; McKenna RM; Walker SM; Bakkestad-Legare P; Jeffrey JR
    Transplant Proc; 1988 Dec; 20(6):1271-3. PubMed ID: 2974206
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro immunosuppressive effect of deoxymethylspergualin.
    Jiang H; Takahara S; Takano Y; Machida M; Iwasaki A; Kokado Y; Kameoka H; Moutabarrik A; Ishibashi M; Sonoda T
    Transplant Proc; 1990 Aug; 22(4):1633-7. PubMed ID: 2143857
    [No Abstract]   [Full Text] [Related]  

  • 12. Synergistic and antagonistic effects of combinations of cyclosporine A and its metabolites on inhibition of phytohemagglutinin-induced lymphocyte transformation in vitro.
    Schultz JC; Lensmeyer GL; Wendal TD; Shahidi NT; Wiebe DA; Carlson IH
    Biochem Pharmacol; 1991 Sep; 42(7):1403-10. PubMed ID: 1834063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the biological activity of cyclosporine metabolites using the human JURKAT cell line.
    Freed BM; Stevens C; Brooks C; Cramer S; Lempert N; Rosano TG
    Transplant Proc; 1991 Feb; 23(1 Pt 2):980-1. PubMed ID: 1989352
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of cyclosporine A on T lymphocytes and accessory cells from human blood.
    Granelli-Piperno A; Keane M
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):136-42. PubMed ID: 2966477
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of FK-506 on human mixed lymphocyte reaction in vitro.
    Kino T; Inamura N; Sakai F; Nakahara K; Goto T; Okuhara M; Kohsaka M; Aoki H; Ochiai T
    Transplant Proc; 1987 Oct; 19(5 Suppl 6):36-9. PubMed ID: 2445071
    [No Abstract]   [Full Text] [Related]  

  • 16. A study of the correlation between cyclophilin binding and in vitro immunosuppressive activity of cyclosporine A and analogues.
    Durette PL; Boger J; Dumont F; Firestone R; Frankshun RA; Koprak SL; Lin CS; Melino MR; Pessolano AA; Pisano J
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):51-7. PubMed ID: 2966482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporin A metabolites suppress T-cell proliferation by concanavalin A and in a mixed lymphocyte reaction.
    Abecassis M; Wong PY; Mason N; Cheung F; Mee AV; Cole EH; Langer B; Cohen Z; Levy GA
    Can J Surg; 1988 May; 31(3):145-50. PubMed ID: 2966666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporine blocks the activation of antigen-dependent cytotoxic T lymphocytes directly by an IL-2-independent mechanism.
    Havele C; Paetkau V
    J Immunol; 1988 May; 140(10):3303-8. PubMed ID: 2966195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gangliosides potentiate cyclosporine A-induced suppression of allospecific immune responses.
    Spagnoli GC; Ausiello CM; Sconocchia G; Adorno D; Casciani CU
    Transplant Proc; 1991 Feb; 23(1 Pt 1):342-5. PubMed ID: 1824985
    [No Abstract]   [Full Text] [Related]  

  • 20. A longitudinal study of the pharmacokinetics of cyclosporine A and in vitro lymphocyte responses in renal transplant patients.
    Tufveson G; Odlind B; Sjöberg O; Lindberg A; Gabrielsson J; Lindström B; Lithell H; Selinus I; Tötterman T; Wahlberg J
    Transplant Proc; 1986 Dec; 18(6 Suppl 5):16-24. PubMed ID: 2947364
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.